History | Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer | Guidance | NICE

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 222 KB)

Published:

18 July 2018
Committee papers TA477 ACD committee papers (PDF 3.16 MB)

Published:

18 July 2018
Committee papers TA447 FAD committee papers (PDF 12.89 MB)

Published:

18 July 2018

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 373 KB)

Published:

06 June 2018
Committee papers (PDF 15.49 MB)

Published:

06 June 2018
Public committee slides (PDF 908 KB)

Published:

06 June 2018

Invitation to participate

Final scope (PDF 254 KB)

Published:

31 October 2017
Final matrix (PDF 261 KB)

Published:

31 October 2017